Variant Bio

Variant Bio is a biotechnology company that develops innovative products in the field of ophthalmology. Variant Bio aims to provide solid proof-of-concept data for the pharmaceutical industry to establish treatment strategies for rare visual disorders. Variant Bio is harnessing the power of human genetic diversity to discover new therapies. The company focuses on identifying individuals and populations with extreme differences in medically relevant trait characteristics worldwide, using innovative sequencing and analysis methods to identify related genes and pathways associated with these traits. By studying the genomes of people with abnormalities in medically relevant traits, genetic research has inspired new treatments for lowering cholesterol and treating osteoporosis.